Project Title:  A Novel Translational Pipeline for the Introduction of New Immune-Based Therapies Targeting Localised and Metastatic Pancreatic Ductal Adenocarcinoma

Professor Brendan Jenkins 300x400

Grant: Innovation Grant 2017

Institution: Hudson Institute of Medical Research

Principal Investigator: Professor Brendan Jenkins

Position Held: Deputy Director, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research

Time required to complete project: 1 year

Project Summary: This project aims to show the preclinical efficacy of a novel series of immune-based therapies across a range of human pancreatic tumours which have been genetically screened to predict treatment responsiveness. This project also addresses the need to identify new genes that can be the target of novel therapeutic approaches.